Technology | May 07, 2013

UltraSPECT Partners with PharmaLogic to Offer Dose Reduction Solution

Hospitals and their patients to benefit from reduced dose and faster exams

May 7, 2013 — UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac and bone imaging applications. The agreement will enable PharmaLogic to provide its hospitals and imaging centers with access to UltraSPECT’s Xpress line of products for lower radiation dose with no diminished image quality.

“UltraSPECT’s proprietary Wide-Beam Reconstruction technology enables our customers to achieve significant radiation dose reduction combined with greater patient comfort and higher throughput capacity,” said Steve Chilinski, president and CEO of PharmaLogic. “Even better, this technology can be easily implemented by retrofitting our customers’ existing facilities without the cost of new imaging camera systems."

Through the use of UltraSPECT’s innovative Wide-Beam Reconstruction (WBR) technology, the products in the company’s portfolio of solutions can provide two unique advantages. They significantly reduce the standard radiopharmaceutical dose requirements for cardiac and bone nuclear medicine imaging exams and/or cut the imaging procedure time in half while maintaining the image quality the facility is accustomed to. Many times they even enhance the image resolution. The company’s Xpress3.Cardiac solution provides benefits — enabling nuclear exams to be performed with 50 percent reduction in both dose and procedure time.

Both patients and technologists benefit from these improvements. With shorter exam times, patient comfort is increased with reduced risk of artifacts from patient movement. Higher image resolution provides greater lesion localization, raising diagnostic confidence and precision. For many UltraSPECT users, the WBR technology results in higher patient throughput for enhanced equipment utilization, higher revenues and greater patient satisfaction and referrals.

UltraSPECT’s product line, utilizing WBR technology, is compatible with most major manufacturers’ nuclear medicine systems as well as clinical software packages.

For more information: www.ultraspect.com

Related Content

Hospital for Special Surgery Invests in Sectra Orthopedic 3-D Planning Software
News | Orthopedic Imaging | January 18, 2018
January 18, 2018 – International medical imaging IT and cybersecurity company Sectra announces that Hospital for Spec
Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
EchoPixel Showcases Next-Generation Surgical Planning With True 3-D Interactive Mixed Reality Software
News | Advanced Visualization | January 08, 2018
January 8, 2018 — EchoPixel showcased the latest version of True 3D, its interactive,...
FDA Announces Final Guidance and Webinar for Technical Considerations for 3-D-Printed Medical Devices
News | 3-D Printing | January 03, 2018
The U.S. Food and Drug Administration (FDA) issued the final version of the guidance, “Technical Considerations for...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs. Dave Fornell
News | Lung Cancer | December 22, 2017
Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City...
News | Enterprise Imaging | December 21, 2017
Vital Images showcased enhancements to its enterprise imaging solutions at the Radiological Society of North America (...
Videos | Neuro Imaging | December 21, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MR
Philips Announces New 3-D Printing Integration With 3D Systems and Stratasys
News | 3-D Printing | December 21, 2017
Philips recently announced agreements with 3D Systems and Stratasys, two global leaders in the 3-D printing industry,...
Overlay Init